Bovine Plasma Market Size to Exceed USD 1,426.9 Mn by 2032

The Bovine Plasma Market, estimated at USD 961.6 Mn in 2025, is expected to exhibit a CAGR of 5.8% and reach USD 1,426.9 Mn by 2032.

The market growth is fueled by rising demand for advanced biotechnology solutions that improve healthcare outcomes, along with increasing adoption in areas such as drug development, diagnostics, and personalized medicine. Innovations in genomics, cell and gene therapies, and biomanufacturing, supported by strong R&D investments, are enhancing treatment effectiveness, efficiency, and accessibility. Furthermore, favorable regulatory support, strategic collaborations, and the growing focus on precision medicine are accelerating market expansion and opening new opportunities for industry participants.

Bovine serum is preferred standard for protein assay. Protein assay are standards to determine the quantity of other proteins present in a sample. Bovine serum albumin (BSA) is a globular protein that is often used as a protein concentration standard in lab experiments as well as in numerous other biochemical applications. It is very useful in different biochemical and life science applications because of its lack of effect in many different biochemical reactions as it does not affect other enzymes. Another useful aspect of bovine serum include that it is small in size and can be easily stored. It is stable at room temperature for up to three weeks.

Global Bovine Plasma Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.

However, the COVID-19 pandemic had a positive impact on the bovine plasma market, owing to the increasing efforts by the key players in the market to develop vaccines for COVID-19 infection. For instance, on June 5, 2025, an article published in American Association for the Advancement of Science, it is found that cow’s antibody can help in neutralization of coronavirus. Cows are excellent factories for producing antibodies, and not simply because they have more blood than smaller animals designed to produce human-like proteins. Their blood can also contain twice as many antibodies per milliliter as human blood.

Thus, increasing efforts by the key players to develop vaccines and carry research and development activities for COVID-19 infection is expected to drive the market growth over the forecast period.

Global Bovine Plasma Market: Key Developments

Bovine plasma is used in forensic research for sample preparation and storage considerations, which is expected to drive the global bovine plasma market growth over the forecast period. For instance, in March 2025, according to the National Center for Biotechnology Information, the whole mammalian blood sources are often used for forensic research and training when human samples cannot be sourced. Bovine, porcine, and equine blood have shown to be viable alternatives to whole human blood for forensic purposes.

The increasing adoption of growth strategies by market players is expected to drive the growth of global bovine market over the forecast period. For instance, on October 27, 2025 Abcam, a global innovator of life science reagents and tools announced the acquisition of BioVision, a company which is engaged in providing tools for drug discovery and biological researches.

Browse 27 Market Data Tables and 31 Figures spread through 156 Pages and in-depth TOC on “Global Bovine Plasma Market”- Forecast to 2032, Global Bovine Plasma Market, by Grade (Technical and Standard), by Origin (U.S., Australia, New Zealand, and Others (Brazil, Mexico, etc.)), by Application (Cell Culture Media, Vaccine Production, Drug Discovery, and Others (Forensic Studies, in vitro diagnostics, etc.)), by End User (Biopharmaceutical Industry, Academic & Research Institutes, and Others (Diagnostic Laboratories, Forensic Laboratories, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/bovine-plasma-market-5467

Moreover, increasing use of bovine plasma in vaccine production is expected to drive the market growth over the forecast period. For instance, on July 15, 2025 a project of generation of biotechnology tools to speed up the drug repurposing process against COVID-19 has been granted by the Ministry of Science and Innovation of the Government of Spain and Centre for the Development of Industrial Technology (CDTI) co-financing with ERDF (European Regional Development Fund). The aim of the project is to generate cell lines stably expressing the proteins necessary for SARS-CoV-2 cell entry.

Key Takeaways of the Global Bovine Plasma Market:

The global bovine plasma market is expected to exhibit a CAGR of 5.8% during the forecast period due to increasing adoption of bovine plasma in drug discovery processes. For instance, on June 6, 2025, an article published in Science Direct stated that plasma protein binding and tissue binding are two of the most crucial parameters for drug discovery. Optimizing plasma protein can be an effective strategy to deliver a candidate molecule for preclinical development with an early indication of sufficient therapeutic index.
Various applications of bovine plasma in different aspects such as food preparation might boost growth of the global bovine plasma market over the forecast period. For instance, on May 20, 2025 an article published in Science Direct, Oleogels made from bovine blood plasma appear to be a suitable replacement for saturated fat in food preparations because they enable the addition of flaxseed oil, a source of linolenic acid that lowers cholesterol and blood sugar levels. In this method, it might create better fat alternatives while simultaneously recovering a waste to provide a more sustainable ingredient.
On the basis of regions, North America is estimated to account for the largest market share in the global bovine plasma market over the forecast period, owing to inorganic activities such as agreements by market players. For instance, on October 1, 2025 Innovative Research, a supplier and manufacturer of human and animal biological reagents, proteins and antibodies finalized its agreement to acquire Molecular Innovations, Inc. This combination of resources of production facility will allow Innovative Research to leverage 30 years of high-quality production and expertise in coagulation and thrombolysis while identifying new areas of product development and investment.
Major players operating in the global bovine plasma market include Thermo Fisher Scientific, Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals, Bovogen Biologicals Pty Ltd, Biowest, Internegocios S.A., ROCKY MOUNTAIN BIOLOGICALS, Sonac, Innovative Research, Lake Immunogenics., Canvax Reagents S.L., Merck KGaA, Cambridge Bioscience Limited, Bio-Techne, VWR International, LLC., Otto Chemie Pvt. Ltd., BioVision Inc, Pel-Freez, LLC, Canvax Reagents S.L., GeneTex, Inc, Cygnus Technologies, Equitech-Bio, and 3H Biomedical AB